Publications by authors named "Stacey B B Dutton"

Mutations in the voltage-gated sodium channel (VGSC) gene SCN1A, encoding the Na1.1 channel, are responsible for a number of epilepsy disorders including genetic epilepsy with febrile seizures plus (GEFS+) and Dravet syndrome (DS). Patients with SCN1A mutations often experience prolonged early-life febrile seizures (FSs), raising the possibility that these events may influence epileptogenesis and lead to more severe adult phenotypes.

View Article and Find Full Text PDF

Mutations in voltage-gated sodium channels expressed highly in the brain (SCN1A, SCN2A, SCN3A, and SCN8A) are responsible for an increasing number of epilepsy syndromes. In particular, mutations in the SCN3A gene, encoding the pore-forming Na1.3 α subunit, have been identified in patients with focal epilepsy.

View Article and Find Full Text PDF
Article Synopsis
  • Loss-of-function mutations in the voltage-gated sodium channel Na1.1 are largely responsible for Dravet syndrome, which leads to severe seizures and cognitive deficits in early life, resulting in a high mortality rate.
  • These mutations are also linked to genetic epilepsy with febrile seizures plus (GEFS+), characterized by early-life seizures and various epilepsy types in adulthood.
  • The study explored the potential of Huperzine A, a natural acetylcholinesterase inhibitor, which showed promise by protecting against seizures in mouse models of Dravet syndrome and GEFS+, suggesting a new treatment avenue for these challenging conditions.
View Article and Find Full Text PDF

Purpose: We evaluated the ability of the ketogenic diet (KD) to improve thresholds to flurothyl-induced seizures in two mouse lines with Scn1a mutations: one that models Dravet syndrome (DS) and another that models genetic (generalized) epilepsy with febrile seizures plus (GEFS+).

Methods: At postnatal day 21, mouse models of DS and GEFS+ were fasted for 12-14 h and then placed on either a 6:1 (fats to proteins and carbohydrates) KD or a standard diet (SD) for 2 weeks. At the end of the 2-week period, we measured thresholds to seizures induced by the chemiconvulsant flurothyl.

View Article and Find Full Text PDF

An average of 15-20% of patients on the ketogenic diet (KD) experience a >50% reduction in seizure frequency; however, 10-40% discontinue the diet due to either a lack of response or adverse side effects. This variability in patient response raises the possibility that genetic factors may influence the efficacy of the KD. As a first step towards identifying these factors, we evaluated the ability of the KD to alter seizure thresholds in four commonly used inbred mouse strains: C57BL/6J, FVB/NJ, A/J, and DBA/2J.

View Article and Find Full Text PDF